Ternary complexes of flurbiprofen with HP-β-CD and ethanolamines characterization and transdermal delivery

Drug Development and Industrial Pharmacy

Volumn 33, Issue 3, 2007, Pages 311-326

  Maitre, Marcos M ^a   Longhi, Marcela R ^a   Granero, Gladys G ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Cyclodextrin; Dissolution; Ethanolamines; Flurbiprofen; Human skin permeation; Inclusion complex

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DIETHANOLAMINE; ETHANOLAMINE; ETHANOLAMINE DERIVATIVE; FLURBIPROFEN; MYRISTIC ACID ISOPROPYL ESTER; PROPYLENE GLYCOL; TRIETHANOLAMINE; WATER;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; NORMAL HUMAN; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; ETHANOLAMINES; FLURBIPROFEN; HUMANS; SKIN ABSORPTION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 34247472565     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600901978     Document Type: Article

References (32)

1. Angiano-Igea, S., Otero-Espinar, F. J., Vila-Jato, J. L., & Blanco-Mendez, J. (1996). Improvement of clofibrate dissolution by complexation with cyclodextrin. Int. J. Pharm., 135, 161-166.
2. Antoniadou-Vyza, E., Buckton, G., Michaleas, S. G., Loukas, Y., & Efentakis, M. (1997). The formation of an inclusion complex of methocarbamol with hydroxypropyl-β-cyclodextrin: the effect on chemical stability, solubility and dissolution rate. Int. J. Pharm., 158, 233-239.
3. Cheong, H.-A. & Choi, H. K. (2002). Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines. Pharm. Res., 19, 1372-1377.
4. Duchêne, D. & Wouessidjewe, D. (1990). Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm., 16, 175-182.
5. Fang, L., Numajiri, S., Kobayashi, D., Ueda, H., Nakayama, K., Miyamae, H., & Morimoto, Y. (2004). Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines. J. Pharm. Sci., 93, 144-154.
6. 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal., 23, 25-31.
7. FDA, Guidance for Industry (1997): Dissolution testing of immediate Release Solid Oral Dosage Forms.
8. Funk, O., Schwabe, L., & Fromming, K. (1969). Freeze-dried preparations of ketoprofen and heptakis-(2,6-dimethyl)-β-cyclodextrin. Drug. Dev. Ind. Pharm., 20, 1957-1969.
9. Gamisans, F., Lacoulonche, A., Chauvet, M., Espina, M., García, M. L., & Egea, M. A. (1999). Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods. Int. J. Pharm., 179, 37-48.
10. Granero, G., Garnero, C., & Longhi, M. (2003). The effect of pH and triethanolamine on sulfisoxale complexation with hydroxypropyl-β- cyclodextrin. Eur. J. Pharm. Sci., 20 (3), 285-293.
11. Harrison, S. M., Barry, B. W., & Dugard, P. H. (1984). Effects of freezing on human skin permeability. J. Pharm. Pharmacol., 36, 261-262.
12. Higuchi, T. & Connors, K., 1965. Phase solubility techniques. In: Reilly, C. (Ed.), Advances in Analytical Chemistry and Instrumentation. Wiley/Interscience, New York, pp. 117-212.
13. Knutson, K., Krill, S. L., & Zhang, J. (1990). Solvent mediated alteration of the stratum corneum. J. Control. Releas., 11, 93-103.
14. Li, P. & Zhao, L. (2003). Solubilization of flurbiprofen in pH-surfactant solutions. J. Pharm. Sci., 92 (5), 951-956.
15. Loftsson, T., Guomundsdottir, H., Sigurjonsdottir, J. F., Sigurosson, H. H., Sigfusson, S. D., Masson, M., & Stefansson, E. (2001). Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int. J. Pharm., 212, 29-40.
16. Loftsson, T. & Masson, M. (2001). Cyclodextrins in topical drug formulations: theory and practice. Int. J. pharm., 225, 15-30.
17. Loftsson, T., Masson, M., Sigurdsson, H. H., Magmusson, P., & Legoffic, F. (1998). Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Die Pharmazie, 53, 137-139.
18. Lopez, R. F. V., Collett, J. H., & Bentley, V. L. B. (2000). Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int. J. Pharm., 200, 127-132.
19. Martindale, The Extra Pharmacopoeia (1989). The Pharmaceutical Press, editors. London, p 18-19.
20. Nakai, Y., Yamamoto, K., Terada, K., & Watanabe, D. (1987). New methods for preparing cyclodextrin inclusion compounds. I. Heating in a sealed container. Chem. Pharm. Bull., 35, 4609-4617.
21. Poul, J., West, J., Buchanan, N., & Grahame, R. (1993). Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. Br. J. Pharmacol., 32, 1000-1003.
22. Potts, R. O. & Guy, R. H. (1995). A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res., 12, 1628-1633.
23. Scalia, S., Villani, S., Scatturin, A., Vandelli, M. A., & Forni, F. (1998). Complexation of the sunscreen agent, butylmethoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int. J. Pharm., 175, 205-213.
24. Schaefer, U. & Loth, H. (1996). An ex vivo model for the study of drug penetration into human skin. Pharm. Res., 13 (Suppl.), 366.
25. 2. Dissolution Technol., 6, 15.
26. Sigurdardóttir, A. M. & Loftsson, T. (1995). The effect of polyvinylpirrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm., 126, 73-78.
27. Szejtli, J. (1994). Medicinal applications of cyclodextrins. Med. Res. Rev., 14, 353-386.
28. Szente L. & Szejtli, J. (1999). Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug Deliv. Rev., 36, 17-28.
29. Tavornvipas, S., Hirayama, F., Arima, H., Uekama, K., Ishiguro, T., Oka, M., Hamayasu, K., & Hashimoto, H. (2002). 6-O-α-(4-O-α-D- glucuronyl) -D-glucosyl-β-cyclodextrin: solubilizing ability and some cellular effects. Int. J. Pharm., 249, 199-209.
30. Uekma, K., Adachi, H., Irie, T., Yano, T., Saita, M., & Noda, K. (1992). Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-β-cyclodextrin and penetration enhancers. J. Pharm. Pharmacol., 44, 119-121.
31. Williams, A. C., Shatri, S. R. S., & Barry, B. W. (1998). Transdermal Permeation Modulation by cyclodextrins: a mechanistic study. Pharm. Dev. Technol., 3, 283-296.
32. Williams, R. O. & Liu, J. (1999). Influence of formulation technique for hydroxypropyl-β-cyclodextrin on the stability of aspirin in HFA 134a. Eur. Pharm. Biopharm., 47, 145-152.